These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 24462240)

  • 1. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
    Petit-Pedrol M; Armangue T; Peng X; Bataller L; Cellucci T; Davis R; McCracken L; Martinez-Hernandez E; Mason WP; Kruer MC; Ritacco DG; Grisold W; Meaney BF; Alcalá C; Sillevis-Smitt P; Titulaer MJ; Balice-Gordon R; Graus F; Dalmau J
    Lancet Neurol; 2014 Mar; 13(3):276-86. PubMed ID: 24462240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
    Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
    Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.
    Lancaster E; Lai M; Peng X; Hughes E; Constantinescu R; Raizer J; Friedman D; Skeen MB; Grisold W; Kimura A; Ohta K; Iizuka T; Guzman M; Graus F; Moss SJ; Balice-Gordon R; Dalmau J
    Lancet Neurol; 2010 Jan; 9(1):67-76. PubMed ID: 19962348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new encephalitis with GABAA receptor antibodies.
    Hirsch LJ
    Lancet Neurol; 2014 Mar; 13(3):239-40. PubMed ID: 24462239
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigations in GABA
    Spatola M; Petit-Pedrol M; Simabukuro MM; Armangue T; Castro FJ; Barcelo Artigues MI; Julià Benique MR; Benson L; Gorman M; Felipe A; Caparó Oblitas RL; Rosenfeld MR; Graus F; Dalmau J
    Neurology; 2017 Mar; 88(11):1012-1020. PubMed ID: 28202703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
    Caputo D; Iorio R; Vigevano F; Fusco L
    Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures.
    Kreye J; Wright SK; van Casteren A; Stöffler L; Machule ML; Reincke SM; Nikolaus M; van Hoof S; Sanchez-Sendin E; Homeyer MA; Cordero Gómez C; Kornau HC; Schmitz D; Kaindl AM; Boehm-Sturm P; Mueller S; Wilson MA; Upadhya MA; Dhangar DR; Greenhill S; Woodhall G; Turko P; Vida I; Garner CC; Wickel J; Geis C; Fukata Y; Fukata M; Prüss H
    J Exp Med; 2021 Nov; 218(11):. PubMed ID: 34546336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
    Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
    Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-gamma-aminobutyric acid receptor type A encephalitis: a review.
    Guo CY; Gelfand JM; Geschwind MD
    Curr Opin Neurol; 2020 Jun; 33(3):372-380. PubMed ID: 32374573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
    Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
    Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of astroglial GABA
    Ismail FS; Faustmann PM
    Epilepsia Open; 2023 Jun; 8(2):692-701. PubMed ID: 37078803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF reactivity in GABA
    Nikolaus M; Kreye J; Turko P; Vida I; Knierim E; Prüss H
    Brain Res; 2019 Feb; 1704():249-256. PubMed ID: 30347219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
    Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
    Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus.
    Lin JJ; Lin KL; Hsia SH; Wang HS; Chou IJ; Lin YT;
    Pediatr Neurol; 2012 Oct; 47(4):252-8. PubMed ID: 22964438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
    van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
    Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.
    Sabater L; Gaig C; Gelpi E; Bataller L; Lewerenz J; Torres-Vega E; Contreras A; Giometto B; Compta Y; Embid C; Vilaseca I; Iranzo A; Santamaría J; Dalmau J; Graus F
    Lancet Neurol; 2014 Jun; 13(6):575-86. PubMed ID: 24703753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe GABA
    Nikolaus M; Knierim E; Meisel C; Kreye J; Prüss H; Schnabel D; Kallinich T
    Eur J Paediatr Neurol; 2018 May; 22(3):558-562. PubMed ID: 29396172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory status epilepticus and autoimmune encephalitis with GABAAR and GAD65 antibodies: A case report.
    Gagnon MM; Savard M; Mourabit Amari K
    Seizure; 2016 Apr; 37():25-7. PubMed ID: 26921483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA
    Maniscalco GT; Mariotto S; Höftberger R; Capra R; Servillo G; Manzo V; Napolitano M; Candelaresi P; Gerevini S; Ferrari S; Bozzetti S; Spatola M; Florio C
    Neurology; 2020 Sep; 95(9):399-401. PubMed ID: 32651290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 42.